Article Hero

Palantir won a three-year contract with the FDA

1607425536.jpg
Miguel A. Rodriguez
Miguel A. Rodriguez
08 Decembrie 2020
Palantir won a three-year contract with the FDA

According to Bloomberg's data, Palantir has recently won a three-year contract with the US Food and Drug Administration. According to the report, the deal is worth $44.4 million. Following the agreement, Palantir will perform drug reviews and inspections.

The deal comes after Palantir had a great Q3 2020 earnings report. Its first report since it became a publicly traded company showed that its revenue grew by 52% to $289 million, topping the $279.3 million consensus. The governmental deals brought Palantir more than $163 million in the past quarter.

In Q4, Palantir is looking for revenues of $300 million, while the market has predicted $296 million.

Following the news, Palantir stock price added 21%. Since September 30, when it went public, its shares jumped 200%.

Read here about how Palantir has performed in Q3!

Sources: cnbc.com, reuters.com

disclaimers_articles

article_share_title

article_rating_title

awful
ok
great
awesome

read_more

Miguel A. Rodriguez
Miguel A. Rodriguez
financial_writer

Miguel a lucrat pentru instituții financiare importante, precum Banco Santander și Banco Central-Hispano. De asemenea, a publicat cărți despre Forex.